Association of Cardiovascular Disease With Respiratory Disease
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.